JNJ-54781532

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-54781532, covering 2014-06-26 to 2019-01-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis [Phase 2]

See pricing